There is growing concern that funding agencies supporting scientific research are increasingly risk-averse, favouring safe projects at the expense of novel projects exploring untested approaches. This column uses the citation trajectories for over 1 million research papers to examine the impact profile of novel research. Novel papers tend to suffer from delayed impact, but are more likely to become big hits in the long run and to generate follow-up research. The short time windows of the bibliometric indicators that are increasingly used by funding agencies in their decision-making may bias funding decisions against novelty.
Related
Most Read
-
Hötte, Somers, Theodorakopoulos
-
Doepke, Hannusch, Kindermann, Tertilt
-
Harrison
-
Hartmann, Leonello, Manganelli, Papoutsi, Schnabel, Sigaux
-
Attinasi, Gerinovics, Gunnella, Mancini, Metelli
-
Burgess, Sievertsen
-
Eichengreen, O'Rourke
-
Mitze, Kosfeld, Rode, Wälde
-
Heldring, Robinson
-
Allen
Blogs&Reviews
-
Carraro, Cœuré, Dhand, Eichengreen, Mills, Rey, Sapir, Schwarzer
-
Evenett
-
Fullerton, Levinson
-
Hoffmann, Moench, Pavlova, Schultefrankenfeld
-
Reichlin, Adam, McKibbin, McMahon, Reis, Ricco, Weder di Mauro
Events
-
7 July - 1 December 2022 / Zoom webinar /
-
11 - 11 July 2022 / online / SUERF - The European Money and Finance Forum BAFFI CAREFIN Bocconi University
-
11 - 13 July 2022 / / National Council of Applied Economic Researach (NCAER)
-
13 - 13 July 2022 / / CEPR and WIPO
-
8 - 19 August 2022 / Online / Harvard Kennedy School Executive Education
CEPR Policy Research
-
Gobillon, Solignac
-
Giglio, Maggiori, Stroebel, Weber
-
Summers, Fatás
-
Favero, Galasso
-
Butt, Churm, McMahon, Morotz, Schanz
-
Eichengreen, Avgouleas, Poiares Maduro, Panizza, Portes, Weder di Mauro, Wyplosz, Zettelmeyer
-
Baldwin, Beck, Bénassy-Quéré, Blanchard, Corsetti, De Grauwe, den Haan, Giavazzi, Gros, Kalemli-Ozcan, Micossi, Papaioannou, Pesenti, Pissarides , Tabellini, Weder di Mauro
-
Baldwin, Nakatomi
-
Thimann
-
Goodhart, Perotti